The upstream components of the Wnt signalling pathway in the dynamic EMT and MET associated with colorectal cancer progression.
about
MAD2B, a novel TCF4-binding protein, modulates TCF4-mediated epithelial-mesenchymal transdifferentiationS100A4 in Cancer Metastasis: Wnt Signaling-Driven Interventions for Metastasis RestrictionFrizzled7: A Promising Achilles' Heel for Targeting the Wnt Receptor Complex to Treat CancerTherapeutic strategies for synchronous and multiple liver metastases from colorectal cancerFrizzled7 as an emerging target for cancer therapyE-cadherin negatively regulates neoplastic growth in non-small cell lung cancer: role of Rho GTPasesEMT is the dominant program in human colon cancer.Prognostic and clinicopathological significance of downregulated E-cadherin expression in patients with non-small cell lung cancer (NSCLC): a meta-analysisCAV1 promotes HCC cell progression and metastasis through Wnt/β-catenin pathway.Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B.Novel clinical therapeutics targeting the epithelial to mesenchymal transitionLEF-1 and TCF4 expression correlate inversely with survival in colorectal cancerAPC/β-catenin-rich complexes at membrane protrusions regulate mammary tumor cell migration and mesenchymal morphologyThe Wnt signalling pathway is upregulated in an in vitro model of acquired tamoxifen resistant breast cancer.Mesenchymal phenotype predisposes lung cancer cells to impaired proliferation and redox stress in response to glutaminase inhibitionDown-regulation of CMTM8 induces epithelial-to-mesenchymal transition-like changes via c-MET/extracellular signal-regulated kinase (ERK) signaling.Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical updateMetformin: an emerging new therapeutic option for targeting cancer stem cells and metastasisN-myc downstream regulated gene 1 (NDRG1) promotes metastasis of human scirrhous gastric cancer cells through epithelial mesenchymal transition.Silibinin inhibits Wnt/β-catenin signaling by suppressing Wnt co-receptor LRP6 expression in human prostate and breast cancer cells.ING5 inhibits epithelial-mesenchymal transition in breast cancer by suppressing PI3K/Akt pathway.SSX2IP promotes metastasis and chemotherapeutic resistance of hepatocellular carcinomaTranslational and clinical implications of the genetic landscape of prostate cancer.Macrophages mediate a switch between canonical and non-canonical Wnt pathways in canine mammary tumors.Treatment with the vascular disruptive agent OXi4503 induces an immediate and widespread epithelial to mesenchymal transition in the surviving tumor.miR-324-3p suppresses migration and invasion by targeting WNT2B in nasopharyngeal carcinoma.Functional and prognostic significance of the genomic amplification of frizzled 6 (FZD6) in breast cancerEpigenetics in cancer stem cells.Targeting signal transduction pathways of cancer stem cells for therapeutic opportunities of metastasis.Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways.Recent advances in understanding the role of diet and obesity in the development of colorectal cancer.The rejuvenated scenario of epithelial-mesenchymal transition (EMT) and cancer metastasis.Epigenetic alterations involved in cancer stem cell reprogramming.Circulating tumour cells and the epithelial mesenchymal transition in colorectal cancer.Clinical significance of epithelial-mesenchymal transition.Phenotypic plasticity and epithelial-to-mesenchymal transition in the behaviour and therapeutic response of oral squamous cell carcinoma.MiR-429 inhibits cells growth and invasion and regulates EMT-related marker genes by targeting Onecut2 in colorectal carcinoma.The epithelial-mesenchymal transition in cancer: a potential critical topic for translational proteomic research.Identification of perturbed signaling pathways from gene expression data using information divergence.Modulatory roles of microRNAs in the regulation of different signalling pathways in large bowel cancer stem cells.
P2860
Q24310703-0C928E28-A7E2-40B2-81AF-84426C44966CQ26743403-1D466B0F-D39D-4CC9-993F-712A34B30119Q26747651-832AD1AE-32AD-45BC-A2AB-4BB92E8E0EA9Q26829522-AF1C840D-2E4D-42BB-B2DB-AF7459E46EBFQ26849278-2F415F0B-00E2-4637-8C5F-02AE5604E54FQ28385103-5AE10CD5-8951-468D-94AF-6083F6E46E97Q33798739-9A1F7ED2-A695-4796-A87F-784A6DA35974Q33825487-3B07E5C4-7564-4368-983F-94194E804FEBQ34122483-5B639A99-42EE-4DB2-B32A-A21E278BFD17Q34292287-B87819C7-B8A4-499D-B506-73F8F654D16DQ34345818-1D94DA01-901B-4195-8BA5-626500A917B3Q34375332-87852AE3-77EB-4048-97CC-B284567D51FFQ34542769-8C66DD01-33A9-4284-9296-CBACC496F631Q34644859-1386A633-4FCA-4818-A285-A7B598A8F6F6Q34691457-3454D4F6-55DD-47B9-BC11-5952D7531C15Q35874388-59F0A119-F747-4BF7-B2B2-CDAD6C0B305AQ35904534-F236C387-D967-4FAE-9A24-BE44DA011397Q36026661-21762382-A1B6-4402-B4CD-79445A5C4E1FQ36109712-BF7BC3F2-24BB-4621-A3B8-F712E739CA3CQ36303639-59929E5A-2D0F-4969-A490-106E5C82759BQ36317550-F9DC1E44-A9F2-4471-90ED-E15E37E2ECFCQ36691348-E5C8B070-2B13-437B-8FB1-9040E51A7A58Q37270512-A032F198-79D6-4839-A070-1CAF288E6C1AQ37431430-E4F56449-CFCE-49CA-B7A9-9C384D48E2B6Q37482536-78EDF130-27B6-468D-ABB7-5F1049A9401CQ37554826-653A0C20-1D17-49D9-AFB8-D22AA228908EQ37595930-47EC75CB-02AF-414B-9D9A-66E822087781Q37618640-6CA5E93F-208A-43D1-956A-CEBD5FEE0955Q37689120-2C0EC567-52EA-4A42-B476-D5F140E792AEQ37820099-CA8B780A-FC0D-4AE3-BC76-2B1735E4AB78Q37850852-0BAF659F-F554-4768-9030-706F791F6E82Q38021684-672E57FB-54D9-4814-ACE7-387D122D0575Q38058972-EB629EBE-EFA1-4C83-96F4-80E2F761C419Q38227766-8F577748-DC0C-45B2-8788-C9E1DFCC0183Q38232585-6769A0FC-2BC2-44FA-8CCC-195FD0106823Q38320920-3308F1F7-AE06-47E8-A9EE-AEB2B649762FQ38586744-100C6C14-A53C-4F0E-9A00-0697338D1DFCQ38633203-77DF3F71-77F3-4311-8FA9-EB01BC2C3AB3Q38681707-749B1DB7-2F01-4D9B-A423-2EF00760D09BQ38681817-BDD0FC2B-69E6-4FB9-951D-280DAAC4DD0B
P2860
The upstream components of the Wnt signalling pathway in the dynamic EMT and MET associated with colorectal cancer progression.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The upstream components of the ...... colorectal cancer progression.
@en
The upstream components of the ...... colorectal cancer progression.
@nl
type
label
The upstream components of the ...... colorectal cancer progression.
@en
The upstream components of the ...... colorectal cancer progression.
@nl
prefLabel
The upstream components of the ...... colorectal cancer progression.
@en
The upstream components of the ...... colorectal cancer progression.
@nl
P1476
The upstream components of the ...... colorectal cancer progression.
@en
P2093
Elizabeth Vincan
Nick Barker
P2888
P304
P356
10.1007/S10585-008-9156-4
P577
2008-03-19T00:00:00Z